Results

Total Results: 522 records

Showing results for "tissue".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay_research-protocol.pdf
    May 02, 2011 - Systemic light-chain (AL) amyloidosis  Amyloid-related systemic syndrome — organ involvement by tissue … Patients with LCMM develop complications related to tissue deposition of light chains, including amyloidosis … provides quantitative results insoluble, Congo red-positive (on histological staining) fibrils in tissues
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/hemorrhage-postpartum_clinician.pdf
    July 01, 2016 - of uterine tone (resulting from one or more of the risk factors listed above), retained placental tissue
  3. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests_executive.pdf
    February 01, 2006 - Typically, suspicious lesions are evaluated with tissue biopsy, either by excision or by needle sampling
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-sepsis.pdf
    July 01, 2023 - an infection, most commonly bacterial, wherein the body’s own immune response causes damage to tissues … response to an infection, most commonly bacterial, wherein the body’s own immune response causes damage to tissues
  5. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rotator-cuff-tear_executive.pdf
    July 01, 2010 - partial-thickness or full-thickness; small, medium, large, or massive; with or without fatty infiltration of muscle tissue … partial-thickness, full-thickness; small, medium, large, or massive; with or without fatty infiltration of muscle tissue
  6. effectivehealthcare.ahrq.gov/health-topics/gum-disease
  7. effectivehealthcare.ahrq.gov/products/lysosomal-storage-diseases-therapies/research-protocol
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ankyloglossia_research-protocol.pdf
    June 30, 2014 - pneumonia, surgical site infection, nerve damage, salivary gland damage, ranulae, scarring, soft tissue … aspiration pneumonia, surgical site infection, nerve damage, salivary gland damage, ranulae, scarring, soft tissue … aspiration pneumonia, surgical site infection, nerve damage, salivary gland damage, ranulae, scarring, soft tissue … pneumonia, surgical site infection, nerve damage, salivary gland damage, ranulae, scarring, soft tissue
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonpharm-treatment-chronic-pain-protocol.pdf
    December 11, 2018 - pain, often defined as pain lasting longer than 3 to 6 months or persisting past the normal time for tissue … chronic pain (defined as pain lasting 12 weeks or longer or pain persisting past the time for normal tissue … Question aChronic pain is defined as pain lasting ≥ 12 weeks or pain persisting past the normal time for tissue … chronic pain (defined as pain lasting 12 weeks or longer or pain persisting past the time for normal tissue
  10. effectivehealthcare.ahrq.gov/health-topics/cardiomyopathy
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-prevention_disposition-comments.pdf
    May 08, 2013 - pressure ulcers include older age, cognitive impairment, and physical impairments that affect soft tissue … Include Deep Tissue Injury. … The Chaplin study (Journal of Tissue Viability, 2000;10:27) was reviewed but does not meet inclusion … There are only 4 numerical stages (stage I, II, III, IV) and 2 others, unstageable and deep tissue … You have not included at all in your description, deep tissue injury (DTI), yet this has been reported
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_research-protocol.pdf
    April 01, 2013 - biopsy, and laboratory tests) or pathological (based on surgery and examination of resected prostate tissue … The cancer cells are incidentally found in 5% or less of resected tissue T1b. … The cancer cells are found in more than 5% of the resected tissue T1c. … repeated, and subsequent treatment is planned3   High-intensity focused ultrasound therapy Tissue … EBRT, including standard therapy and therapies designed to decrease exposure to normal tissues such
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_executive.pdf
    April 01, 2012 - glaucoma from other optic neuropathies include excavation and undermining of the neural and connective tissues … The probe is used to disrupt tissue that is typically impeding outflow of aqueous humor from the … A second flap is dissected below this flap in order to leave a very thin layer of tissue and to expose … Aqueous humor is able to permeate the remaining tissue without a full-thickness hole being necessary … The Trabectome uses low-energy electrical pulses to vaporize the trabecular tissue, and aspiration
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
    January 01, 2015 - Lymphocytic Leukemia and Mantle Cell Lymphoma Automated Breast Ultrasound Screening for Dense Breast Tissue … Invenia Automated Breast Ultrasound System, Formerly Called somo•v) for Screening Dense Breast Tissue … Assuming that 4 million of 20 million women who have dense breast tissue in the United States have a … accuracy for dense breasts, ABUS could offer a much less costly option for screening dense breast tissue … If implemented today, we estimated ovarian tissue cryopreservation would cost about $1.2 billion, assuming
  15. effectivehealthcare.ahrq.gov/products/infantile-hemangioma/research-protocol
  16. effectivehealthcare.ahrq.gov/sites/default/files/cer-249-malnutrition-hospitalized-adults-evidence-summary.pdf
    October 01, 2021 - matter experts, imaging modalities to quantify and evalute body composition (i.e., muscle and adipose tissues
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-249-malnutrition-hospitalized-adults-evidence-summary_0.pdf
    October 01, 2021 - matter experts, imaging modalities to quantify and evalute body composition (i.e., muscle and adipose tissues
  18. CERs Report cover (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/future05-breastcancer-10-5-2010final.pdf
    September 01, 2010 - Tibolone (STEAR: Selective Tissue Estrogenic Activity Regulator) 20.0% (2) 40.0% (4) 40.0% … Risk Prediction for Breast Cancer: A Tissue-based Strategy. 2008. 34. … Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, … Collecting Samples of Normal Breast Tissue, Primary Breast Cancer Tissue, and Metastatic Breast Cancer … Tissue for Genetic Analysis in Women With or Without Breast Cancer. 68. 5R03CA141485-02.
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
    October 25, 2010 - Tibolone (STEAR: Selective Tissue Estrogenic Activity Regulator) 20.0% (2) 40.0% (4) 40.0% … Risk Prediction for Breast Cancer: A Tissue-based Strategy. 2008. 34. … Collecting Samples of Normal Breast Tissue, Primary Breast Cancer Tissue, and Metastatic Breast Cancer … Tissue for Genetic Analysis in Women With or Without Breast Cancer. 68. 5R03CA141485-02. … Monitoring of Breast Tissue Change Due to Hormone Replacement Therapy in Post-menopausal Women Using
  20. effectivehealthcare.ahrq.gov/health-topics/chiari-malformation

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: